Ampligen clinical trials

A Phase 2, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma

This study is looking at a new medicine called Ampligen for people with pancreatic cancer that has spread nearby but not to other parts of the body. It aims to see if Ampligen can stop the cancer from growing for longer. It's in an early stage of testing.